SCHEMBL1428753

SCHEMBL1428753

CNC(=O)Nc1ccc2c(c1)C(=O)C(=Cc1c[nH]c3c(/C=C/CN(C)C)cc(OC)cc13)O2

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PIK3CA P42336 15/20 0.50
MTOR P42345 14/20 0.48
PIK3CG P48736 2/20 0.42
PIK3CD O00329 1/20 0.42
PIK3CB P42338 1/20 0.42
PIM1 P11309 1/20 0.37
AURKA O14965 1/20 0.34
DAPK3 O43293 1/20 0.34
STK17B O94768 1/20 0.34
GSK3B P49841 1/20 0.34
BLK P51451 1/20 0.34
CDK5 Q00535 1/20 0.34
TEK Q02763 1/20 0.34
BTK Q06187 1/20 0.34
ITK Q08881 1/20 0.34
STK17A Q9UEE5 1/20 0.34
DAPK2 Q9UIK4 1/20 0.34
MEN1 O00255 1/20 0.33
NPC1 O15118 1/20 0.33
RAB9A P51151 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4325732 1.00 PIK3CA (0.50) PIK3CAMTORPIK3CGPIK3CDPIK3CB
SCHEMBL1428756 1.00 PIK3CA (0.50) PIK3CAMTORPIK3CGPIK3CDPIK3CB
SCHEMBL4325623 0.87 PIK3CA (0.52) PIK3CAMTORPIK3CGPIK3CDPIK3CB
SCHEMBL1428686 0.87 PIK3CA (0.52) PIK3CAMTORPIK3CGPIK3CDPIK3CB
SCHEMBL1428688 0.87 PIK3CA (0.52) PIK3CAMTORPIK3CGPIK3CDPIK3CB
SCHEMBL4319556 0.87 PIK3CA (0.58) PIK3CAMTORPIK3CGPIK3CDPIK3CB
SCHEMBL4319551 0.87 PIK3CA (0.58) PIK3CAMTORPIK3CGPIK3CDPIK3CB
SCHEMBL4321570 0.83 PIK3CA (0.52) PIK3CAMTORPIK3CGPIK3CDPIK3CB
SCHEMBL4321576 0.83 PIK3CA (0.52) PIK3CAMTORPIK3CGPIK3CDPIK3CB
SCHEMBL4330300 0.81 PIK3CA (0.71) PIK3CAMTORPIK3CGAURKADAPK3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2300460-A1 3-SUBSTITUTED-1H-INDOLE COMPOUNDS, THEIR USE AS MTOR KINASE AND PI3 KINASE INHIBITORS, AND THEIR SYNTHESES Wyeth LLC (US) 2011-03-30 EP claimed
WO-2009155042-A1 3-SUBSTITUTED-1H-INDOLE COMPOUNDS, THEIR USE AS MTOR KINASE AND PI3 KINASE INHIBITORS, AND THEIR SYNTHESES WYETH (US) 2009-12-23 WO claimed
US-20090311217-A1 3-SUBSTITUTED-1H-INDOLE COMPOUNDS, THEIR USE AS MTOR KINASE AND PI3 KINASE INHIBITORS, AND THEIR SYNTHESES WYETH (US) 2009-12-17 US claimed
EP-2300460-A1 3-SUBSTITUTED-1H-INDOLE COMPOUNDS, THEIR USE AS MTOR KINASE AND PI3 KINASE INHIBITORS, AND THEIR SYNTHESES Wyeth LLC (US) 2011-03-30 EP disclosed
WO-2009155042-A1 3-SUBSTITUTED-1H-INDOLE COMPOUNDS, THEIR USE AS MTOR KINASE AND PI3 KINASE INHIBITORS, AND THEIR SYNTHESES WYETH (US) 2009-12-23 WO disclosed
US-20090311217-A1 3-SUBSTITUTED-1H-INDOLE COMPOUNDS, THEIR USE AS MTOR KINASE AND PI3 KINASE INHIBITORS, AND THEIR SYNTHESES WYETH (US) 2009-12-17 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090311217-A1 3-SUBSTITUTED-1H-INDOLE COMPOUNDS, THEIR USE AS MTOR KINASE AND PI3 KINASE INHIBITORS, AND THEIR SYNTHESES MTOR, RICTOR, PDPK1 PIK3CA 4/4885MTOR 1/4885PIK3CG 8/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.